← back to search

Wolfgang Arns

Charité - Universitätsmedizin Berlin · DE
Area of research
Transplantation · Surgery
Research interest
Research interests include Medicine, Everolimus, Kidney transplantation, Transplantation, Calcineurin, and Internal medicine.
h-index
citations
514
works
10
NIH funding
primary concept
email

Recent publications

Impact of everolimus plus calcineurin inhibitor on formation of non-HLA antibodies and graft outcomes in kidney transplant recipients: 12-month results from the ATHENA substudy
Frontiers in Transplantation 2023cited by 5position: middledoi
Everolimus plus reduced calcineurin inhibitor prevents de novo anti-HLA antibodies and humoral rejection in kidney transplant recipients: 12-month results from the ATHENA study
Frontiers in Transplantation 2023cited by 3position: firstdoi
Repeated kidney re‐transplantation—the Eurotransplant experience: a retrospective multicenter outcome analysis
Transplant International 2020cited by 21position: middledoi
Should kidney allografts from old donors be allocated only to old recipients?
Transplant International 2020cited by 16position: middledoi
Preformed Donor-Specific HLA Antibodies in Living and Deceased Donor Transplantation
Clinical Journal of the American Society of Nephrology 2019cited by 70position: middledoi
Everolimus with cyclosporine withdrawal or low-exposure cyclosporine in kidney transplantation from Month 3: a multicentre, randomized trial
Nephrology Dialysis Transplantation 2017cited by 35position: middledoi
High-urgency kidney transplantation in the Eurotransplant Kidney Allocation System: success or waste of organs? The Eurotransplant 15-year all-centre survey
Nephrology Dialysis Transplantation 2016cited by 18position: middledoi
Five-Year Outcomes in Kidney Transplant Patients Converted From Cyclosporine to Everolimus: The Randomized ZEUS Study
American Journal of Transplantation 2014cited by 126position: middledoi
Preemptive treatment of Cytomegalovirus infection in kidney transplant recipients with letermovir: results of a Phase 2a study
Transplant International 2013cited by 136position: middledoi
Conversion From Cyclosporine to Everolimus at 4.5 Months Posttransplant: 3-Year Results From the Randomized ZEUS Study
American Journal of Transplantation 2012cited by 84position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Claudia Sommerer · Heidelberg University5 papers (2012–2023)Klemens Budde · Humboldt-Universität zu Berlin4 papers (2012–2017)Oliver Witzke · Technische Universität Dresden4 papers (2012–2017)Ingeborg A. Hauser · KfH Kuratorium für Dialyse und Nierentransplantation3 papers (2017–2023) · 3 papers (2013–2023) · 3 papers (2012–2014)Frank Lehner · Fachhochschule Wiener Neustadt3 papers (2012–2017)Duska Dragun · Humboldt-Universität zu Berlin2 papers (2023–2023) · 2 papers (2023–2023) · 2 papers (2023–2023) · 2 papers (2012–2014)Martina Porstner · Friedrich-Alexander-Universität Erlangen-Nürnberg2 papers (2014–2017) · 2 papers (2012–2017)Eva‐Maria Paulus · Novartis (Switzerland)2 papers (2012–2017) · 2 papers (2023–2023)Ute Eisenberger · KU Leuven2 papers (2012–2014) · 2 papers (2023–2023)Aurélie Philippe · Humboldt-Universität zu Berlin2 papers (2023–2023) · 2 papers (2023–2023)Björn Nashan · Medizinische Hochschule Hannover2 papers (2023–2023)